EID Parry (India) Ltd(EIDPARRY)

NSE: EIDPARRYBSE: 500125

₹ 622.1-1.00%refreshed 26 Oct, 03:56 pm ISTMarket cap: ₹ 11,071 crWebsite: www.eidparry.comUpdated: 27 Oct 2026

About

EID Parry (India) Ltd is a Chennai-based diversified agri-business with integrated operations in sugar, ethanol, cogeneration, nutraceuticals and consumer products, and holds a controlling stake in Coromandel International Limited (fertilizers and crop protection). EID Parry is India's first sugar producer (since 1842) and holds approximately 55% market share in the branded sweeteners segment across Southern India.^[1][2][3]

Products and brands

Consumer products sold under the 'Parrys' brand - the only sugar brand to receive Superbrand recognition for five consecutive years (2021 - 2025).^[3]
CPG portfolio spans plantation white sugar, refined sugar, specialty sugars, jaggery powder, brown sugar, low-GI sugar, and staples including rice, pulses and millets.^[3]
Nutraceuticals portfolio covers organic spirulina, chlorella, carotenoids, astaxanthin and lutein/zeaxanthin; US subsidiary Valensa markets Serevelle (hair health) and USPlus® PRO (men's urinary health).^[3]
EID Parry is the only USP-verified spirulina manufacturer globally and the only sugar company in India with an in-house sugarcane breeding station at Haliyal, Karnataka.^[3]

Manufacturing capacity and locations

Aggregate sugarcane crushing capacity of approximately 40,800 TCD across seven plants: Nellikuppam 7,500 TCD, Pugalur 4,800 TCD, Haliyal-1 7,000 TCD, Haliyal-2 5,000 TCD, Bagalkot 6,500 TCD, Ramdurg 5,000 TCD and Sankili 5,000 TCD.^[3]
Cogeneration capacity of about 140 MW and distillery capacity of about 582 KLPD across operating locations.^[3]
Nutraceutical production capacity of 400 MT spirulina and 30 MT chlorella; nutraceutical factories at Oonaiyur and Saveriyarpuram (Tamil Nadu).^[3]
DSIR-recognised R&D centres at Pugalur and Nellikuppam (Tamil Nadu); sugarcane germplasm repository of 1,590 accessions at Haliyal. Total R&D investment was Rs 3.5 crores in FY26.^[3]

Key operating numbers

Sugar sold 0.89 LMT in Q1 FY27 vs 0.56 LMT in Q1 FY26; average selling price Rs 40.02/kg vs Rs 40.97/kg; cane landed cost Rs 4,031/MT vs Rs 3,844/MT.^[4]
Gross sugar recovery rate 7.95% in Q1 FY27 vs 8.02% prior year; cane crushed 1.47 LMT vs 2.12 LMT.^[4]
Distillery sold 380 lakh litres in Q1 FY27 vs 413 LL prior year; average realisation Rs 63.49/litre vs Rs 67.59/litre (mix: ENA 138 LL + ethanol 242 LL).^[4]
Full-year FY26 alcohol (ENA and ethanol) production and sales approximately 1,635 lakh litres; distillery operates multi-feedstock routes across B-heavy molasses, C-heavy molasses, syrup and grain.^[3]
Power exported 89 lakh units in Q1 FY27 vs 122 lakh units prior year; tariff realised Rs 4.89/unit vs Rs 3.67/unit.^[4]
CPG turnover Rs 94 crores in Q1 FY27 vs Rs 188 crores in Q1 FY26, following a deliberate pivot away from low-margin volumes; absolute contribution margin pool grew despite revenue decline.^[4]
Consolidated nutraceuticals revenue Rs 61 crores in Q1 FY27 vs Rs 27 crores in Q1 FY26, driven by Valensa new product launches in derma, hair and skin health.^[4]
Nutraceuticals achieved approximately 90% of production targets for organic spirulina in FY26 despite geopolitical and market-related disruptions.^[3]

Customers and distribution

Institutional sugar and specialty sugar supplied to multinational beverage, confectionery, pharmaceutical and institutional customers; ENA and ethanol supplied to IMFL manufacturers and Oil Marketing Companies (OMCs).^[3]
EID Parry holds approximately 55% market share in the branded sweeteners segment across Southern India; CPG distribution reach was 1 - 1.2 lakh outlets as of Q3 FY26.^[3][5]
Nutraceuticals business exports to over 20 countries across North America, Europe, Asia-Pacific, Australia and New Zealand.^[3]
The company works with over 1,50,000 farmer partners for sugarcane supply.^[3]

Expansion and capex

New jaggery plant in Karnataka at approximately Rs 45 crores capex, expected to be commissioned within 6 months of Q1 FY27; will more than double current jaggery capacity.^[4][6]
Once both the existing and new Karnataka jaggery plants are operational, combined jaggery turnover is targeted at close to Rs 100 crores.^[4]
No other capital expenditure is planned for FY27 beyond the new jaggery facility.^[6]
Non-core land parcels to be monetised in FY27 to reduce debt; quantum and timeline not specified.^[4]

Recent developments

PSRIPL (sugar refinery subsidiary) ceased operations on March 31, 2026; EID Parry recognised an impairment of Rs 40,060 lakhs and a provision of Rs 59,132 lakhs for financial guarantee obligations.^[3]
EID Parry infused Rs 665 crores (Rs 610 cr equity + Rs 55 cr loan) into PSRIPL during Q1 FY27; all PSRIPL bank liabilities fully settled as of the Q1 FY27 call.^[4]
An in-principle SEZ debonding letter for PSRIPL was received on April 20, 2026; full closure and plant/machinery liquidation targeted by September 30, 2026.^[4]
Board approved on February 12, 2026 an enabling resolution to sell up to 1,500,000 equity shares of Coromandel International Limited (0.51% of CIL's paid-up capital).^[5]
Domestic sugar prices moved above Rs 45 - 46/kg in August 2026 on El Niño concerns; management is evaluating the optimal split between sugar production and ethanol while honouring committed OMC volumes.^[4]
VSS (voluntary separation scheme) launched at legacy plants to structurally reduce fixed employee costs; further VSS rounds planned beyond Q1 FY27.^[4]

Market Cap

₹11,071 Cr

High / Low

₹1,117 / 623

Stock P/E

23.9

Price / Book

1.3

Book Value

₹493

EPS

₹32.0

No. of Shares

17.79 Cr

ROCE

18.1%

ROE

6.8%

OPM

7.8%

Debt / Equity

0.33

Sales

₹38,534 Cr

Net Profit

₹1,380 Cr

Promoter holding

41.3%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials

EID Parry (India) Ltd(EIDPARRY)

About

Products and brands

Manufacturing capacity and locations

Key operating numbers

Customers and distribution

Expansion and capex

Recent developments

Signal history

The analysis Screener can't give you

AI Deep Dive

Verdict

Company data

Product Segments

Corporate Actions